Friday-Sunday, November 8-10, 2019, Hollywood, Florida

The First Annual Oncology Nursing Retreat

November 8-10, 2019

The Diplomat
3555 South Ocean Drive
Hollywood, FL 33019
Hotel Phone: (954) 602-6000

Meeting Room
Atlantic Ballroom (Convention Center Level 2)

Hotel Accommodations
A special discounted room rate of $199 (plus applicable tax and resort fee) is available to conference attendees at The Diplomat. Please see the Location tab for additional details.

Note from the Moderator
This coming November will mark the inaugural year of the Oncology Nursing Retreat. Focusing on a plethora of common solid tumors and hematologic cancers, this one-of-a-kind offering will span parts of 3 days and feature a stellar faculty panel of clinical investigators and nurse practitioners and a unique blend of short didactic presentations, lively moderated panel and case discussions and dedicated Q&A sessions. To make the conference truly interactive, each nurse in attendance will be provided with a specially configured iPad® to use throughout the program to participate in audience polling, view all the presentation slides and anonymously submit questions to the panelists. The educational design of the conference and the topics to be discussed will offer attendees the opportunity to access the in-depth perspectives of some of the top minds in the field on issues prevalent in contemporary oncology nursing practice.

So as you begin to make your plans for this fall, we hope you will join us in sunny South Florida for an unparalleled accredited learning experience.

Neil Love, MD
Research To Practice
Miami, Florida



Keynote Panel

Rhonda Hewitt, MSN, RN, ANP-BC, AOCNP
Hematology Nurse Practitioner
Stanford Health Care
Stanford, California

Daniel A Pollyea, MD, MS
Associate Professor of Medicine
Clinical Director of Leukemia Services
Robert H Allen Endowed Chair in Hematology Research
Division of Hematology
University of Colorado School of Medicine
Aurora, Colorado

Eytan M Stein, MD
Hematologist and Medical Oncologist
Assistant Attending Physician
Leukemia Service
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

Lauren Ziskind, APN, NP-C, OCN
Nurse Practitioner
Adult Leukemia Program
The University of Chicago
Chicago, Illinois


Colorectal and Gastric Cancer

Johanna Bendell, MD
Chief Development Officer
Director, Drug Development Unit Nashville
Sarah Cannon Research Institute
Nashville, Tennessee

Amanda Wagner, APRN-CNP, AOCNP
The Arthur G James Cancer Hospital
Martha Morehouse Medical Plaza
GI Medical Oncology
Columbus, Ohio

Hepatocellular Carcinoma and Pancreatic Cancer

Jessica Mitchell, APRN, CNP, MPH
Assistant Professor of Oncology
Mayo College of Medicine
Rochester, Minnesota

Eileen M O’Reilly, MD
Winthrop Rockefeller Chair in Medical Oncology
Section Head, Hepatopancreaticobiliary/
Neuroendocrine Cancers
Gastrointestinal Oncology Service
Associate Director, David M Rubenstein Center for Pancreatic Cancer
Attending Physician, Member
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, New York

Chronic Lymphocytic Leukemia

Josie Bazemore, MSN, AGPCNP-BC
Dana-Farber Cancer Institute
Boston, Massachusetts

Matthew S Davids, MD, MMSc
Assistant Professor of Medicine
Harvard Medical School
Director, DFCI Lymphoma BioBank
Associate Director, CLL Center
Dana-Farber Cancer Institute
Boston, Massachusetts

Hodgkin and Non-Hodgkin Lymphomas

Amy Goodrich, CRNP
Nurse Practitioner

The Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins Medicine
Baltimore, Maryland

Ann S LaCasce, MD, MMSc
Program Director, Dana-Farber/Partners Fellowship in Hematology/Oncology
Associate Professor of Medicine
Institute Physician
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts

Multiple Myeloma

Morie A Gertz, MD, MACP
Consultant, Division of Hematology
Roland Seidler Jr Professor and Chair
Department of Medicine
College of Medicine
Mayo Distinguished Clinician
Mayo Clinic
Rochester, Minnesota

Tiffany Richards, MS, ANP-BC, AOCNP
Nurse Practitioner
Department of Lymphoma/Myeloma
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Prostate Cancer

Daniel P Petrylak, MD
Professor of Internal Medicine (Medical Oncology) and Urology
Yale University
New Haven, Connecticut

Victoria Sinibaldi, RN, MS, CS, CANP, BC
Adult and Geriatric Nurse Practitioner
Research Associate in Oncology
Faculty, School of Medicine
Research Program Coordinator, GU Oncology
Johns Hopkins University
Baltimore, Maryland

Renal Cell Carcinoma and Bladder Cancer

David I Quinn, MBBS, PhD
Medical Director
Norris Cancer Hospital and Clinics
Head, GU Cancer Section
Division of Cancer Medicine and Blood Diseases
USC Norris Comprehensive Cancer Center
Los Angeles, California

Susan K Roethke, CRNP, MSN, ANP-BC, AOCNP
Genitourinary Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

ER-Positive, HER2-Negative Breast Cancer

Sara A Hurvitz, MD
Associate Professor of Medicine
Director, Breast Oncology Program
Division of Hematology/Oncology
University of California, Los Angeles
Medical Director, Jonsson Comprehensive Cancer Center Clinical Research Unit
Los Angeles, California
Co-Director, Santa Monica-UCLA Outpatient Oncology Practices
Santa Monica, California

Elizabeth O’Reilly, RN, NP, MSN, MPH
Nurse Practitioner, Breast Oncology
Susan F Smith Center for Women’s Cancers
Dana-Farber Cancer Institute
Boston, Massachusetts

HER2-Positive and Triple-Negative Breast Cancer

Jamie Carroll, APRN, MSN, CNP
Mayo Clinic
Rochester, Minnesota

Hope S Rugo, MD
Professor of Medicine
Director, Breast Oncology and Clinical Trials Education
University of California, San Francisco Medical Center
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California



Rami Komrokji, MD
Senior Member
Section Head – Leukemia and MDS
Vice Chair – Department of
Malignant Hematology
H Lee Moffitt Cancer Center
Professor of Oncologic Sciences
University of South Florida
Tampa, Florida

Sarah K Swanson, ANP-BC
Rush University Medical Center
Department of Hematology, Oncology and
Cell Therapy
Chicago, Illinois


Katherine Benchich, NP, MSN, RN
Hematology Oncology
UCHealth Cancer Care
Anschutz Medical Campus
University of Colorado Cancer Center
Denver, Colorado

Evan J Lipson, MD
Associate Professor, Medical Oncology
Johns Hopkins University School of Medicine
Bloomberg-Kimmel Institute for Cancer Immunotherapy
The Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland

Gynecologic Cancers

Paula J Anastasia, RN, MN, AOCN
Gyn-Oncology Clinical Nurse Specialist
Cedars-Sinai Medical Center
Los Angeles, California

Kathleen Moore, MD
Jim and Christy Everest Endowed Chair in Cancer Research
Associate Director, Clinical Research
Director, Oklahoma TSET Phase I Program
Stephenson Cancer Center
Associate Professor, Section of Gynecologic Oncology
Director, Gynecologic Oncology Fellowship
Department of Obstetrics and Gynecology
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma

Targeted Treatment of Lung Cancer

Wendi S Lee, MSN, RN, NP-C
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Anne S Tsao, MD

Director, Mesothelioma Program

Director, Thoracic Chemo-Radiation Program

Section Chief, Thoracic
Department of Thoracic/Head and Neck
Medical Oncology
The University of Texas
MD Anderson Cancer Center

Houston, Texas

Immunotherapy for Locally Advanced and Metastatic Lung Cancer

Kelly EH Goodwin, MSN, RN, ANP-BC
Thoracic Cancer Center
Massachusetts General Hospital
Boston, Massachusetts

Matthew Gubens, MD, MS
Associate Professor, Thoracic Medical Oncology
University of California, San Francisco
San Francisco, California

Full agenda and speaker information will be made available later this summer. Times and schedule are subject to change.

Preliminary Agenda

Friday, November 8th
  • 6:30 PM – 7:15 PM
  • 7:15 PM – 7:45 PM
  • 7:45 PM – 8:30 PM
  • Welcome Reception
  • Keynote Lecture
  • Q&A Session
Saturday, November 9th
  • 7:00 AM – 8:00 AM
  • 8:00 AM – 12:30 PM
  • 12:30 PM – 1:30 PM
  • 1:30 PM – 4:30 PM
  • Breakfast
  • Morning General Session
  • Lunch
  • Afternoon General Session
Sunday, November 10th
  • 7:00 AM – 8:00 AM
  • 8:00 AM – 12:45 PM
  • 12:45 PM
  • Breakfast
  • General Session
  • Meeting adjourns

Target Audience
This activity has been designed to meet the educational needs of oncology nurses, nurse practitioners and clinical nurse specialists involved in the treatment of cancer.

Accreditation Statement
Research To Practice (RTP) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation.

Credit Designation Statement
This educational activity for 13.25 contact hours is provided by RTP.

This activity is awarded 13.25 ANCC pharmacotherapeutic contact hours.

To obtain a certificate of completion and receive credit for this event, nurses must sign in at the registration desk upon arrival, attend the entire activity and return a completed Educational Assessment and Credit Form upon exiting the activity.

Oncology Nursing Certification Corporation (ONCC)/Individual Learning Needs Assessment (ILNA) Certification Information
This program will be submitted for ONCC/ILNA certification.

Unlabeled/Unapproved Uses Notice
There is no implied or real endorsement of any product by RTP or the ANCC. Any off-label use as declared by the FDA will be identified.

Content Validation and Disclosures
RTP is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess conflicts of interest with faculty, planners and managers of CNE activities. Conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations. Financial disclosures will be provided in meeting course materials.

RTP CNE planning committee members, staff and reviewers — Planners, scientific staff and independent reviewers for RTP have no relevant conflicts of interest to disclose.

Educational Support
This activity is supported by educational grants from AbbVie Inc, Array BioPharma Inc, Astellas and Pfizer Inc, AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb Company, Eisai Inc, Incyte Corporation, Lilly, Loxo Oncology Inc, a wholly owned subsidiary of Eli Lilly & Company, Merck, Novartis, Sanofi Genzyme, Seattle Genetics, and Taiho Oncology Inc.

The Diplomat
3555 South Ocean Drive
Hollywood, FL 33019
Hotel Phone: (954) 602-6000

Meeting Room
Atlantic Ballroom (Convention Center Level 2)

The Diplomat offers both valet and overnight parking. Parking rates are as follows: overnight parking is $37.45 and daily valet parking is $25 plus taxes/service fees. The Diplomat also has a self-parking lot across the street from the hotel. Parking rates there are as follows: overnight self-parking is $25 plus taxes/service fees and daily self-parking is $15 plus taxes/service fees. Please note that unfortunately, due to regulatory reporting requirements, Research To Practice is unable to validate parking.

Room Reservations
A special discounted room rate of $199 (plus discounted resort fee of $13 and applicable room taxes) is available to conference attendees at The Diplomat hotel. To secure accommodations, please contact The Diplomat directly at (855) 689-2911 or (954) 602-6000. A personal credit card will be required to secure accommodations with a 1-night room deposit. Please mention you are participating in the First Annual Oncology Nursing Retreat to receive the special group rate.

Room reservations must be made by Wednesday, October 9, 2019. A limited number of rooms are available, and we encourage you to make your reservations early. After Wednesday, October 9, 2019, the hotel will offer the best rates based on room availability.

For driving and public transportation directions to The Diplomat, please visit the resort website.

This activity has been designed to meet the educational needs of oncology nurses, nurse practitioners and clinical nurse specialists involved in the treatment of cancer.

Registration Fees

  • For oncology nurses or other clinicians in practice caring for patients, registration is free and includes full access to the conference sessions, meal functions and discounted hotel accommodations within the conference housing block. If you have any questions, please contact our Meeting Services department at or call (800) 233-6153.
  • For all other individuals, including industry professionals,* a conference registration fee of $850 is available through October 31, 2019 and then $950 after that day. This registration fee includes full access to the conference sessions, meal functions and discounted hotel accommodations within the conference housing block. All fees processed will be nonrefundable after November 1, 2019 (5:00 PM Eastern Time). To cancel your registration, please contact our Meeting Services department at or call (800) 233-6153.

Registration for oncology nurses and other clinicians in practice

I am a practicing oncology nurse, nurse practitioner, clinical nurse specialist or other clinician in practice involved in the treatment of cancer.

Registration for clinicians in practice »
Registration for other/industry professionals*

Please note, a limited number of seats are currently available for nonclinicians on a first come, first served basis.

Registration for other/industry professionals »

* Individuals employed by for-profit organizations, including financial institutions, biotech or pharmaceutical companies
Registration for groups
If you are registering a group (more than 1 person) for this event, please contact us at or (800) 233-6153.
To ensure seating, please check in at our onsite registration desk at least 30 minutes before the start of the meeting. We cannot guarantee seating after the start of the program.

Meal service will be provided to those who attend the program, based on availability.

Photography and/or video recording may be taken during the educational program by Research To Practice and used in future educational programs.

Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153.